Mutants of human antithrobin III and methods for their productio

Details Mutants of human antithrobin III and methods for their productio Mutants of human antithrobin III and methods for their productio

1995-05-30

1997-12-23

Patterson, Jr., Charles L.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

435226, 530380, 514 12, A61K 3817, C07K 1447

Patent

active

057006636

ABSTRACT:
Mutants of AT III which have been advantageously modified at one or more potential glycosylation sites or at the Arg393 position are described. As a rule, combination of the mutations enhances the advantageous modifications.

REFERENCES:
patent: 4632981 (1986-12-01), Bock
Zettlmeissl et al., "Influence of Glycosylation on the Functional Properties of Human Therapeutic Plasma Proteins", Protein Glycosylation: Cellular, Biotechnological and Analytical Aspects, GBF Monographs, vol. 15 (ed. H.5. Conradt), pp. 259-268, 1991.
Bowie et al., "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions", Science, vol. 247, pp. 1306-1310, Mar. 1990.
J. Schrader et al., "Chromogene Substratmethoden zur Antithrombin III-Bestimmung", Des Arztliche Laboratorium, pp. 111-114, (1986).
G. Zettlmeissl et al., "Expression of Biologically Active Human Anti-thrombin III in Chinese Hamster Ovary Cells", Bio/Technology, vol. 5, pp. 720-725 (Jul. 1987).
M. Hoylaerts et al., "Involvement of Heparin Chain Length in the Heparin-catalyzed Inhibition of Thrombin by Antithrombin III", J. Biol. Chem., vol. 259, No. 9, pp. 5670-5677 (May 1984).
C. Peterson et al., "Isolation and Characterization of an Antithrombin III Variant with Reduced Carbohydrate Content and Enhanced Heparin Binding", J. Biol. Chem., vol. 260, No. 1, pp. 610-615 (Jan. 1985).
S. Brennan et al., "Physiological Variant of Antithrombin-III Lacks Carbohydrate Sidechain at Asn 135", FEBS Letters, vol. 219, No. 2, pp. 431-436 (Jul. 1987).
Yansushi Morinaga et al., "Improvement of Oligonucleotide-Directed Site-Specific Mutagenesis Using Double-Stranded Plasmid DNA", Bio/Technology, pp. 636-639 (Jul. 1984).
Jorgensen et al., Biochem. J. 231; 59-63 (1985).
Molho-Sabatier et al., J. Clin. Invest. 84; 1236-1242 (1989).
W. Kramer et al., "The Gapped Duplex DNA Approach to Oligonucleotide-Directed Mutation Construction", Nucl. Acids Res., vol. 12, No. 24, pp. 9441-9456 (1984).
G. Zettlmeissl et al., "Efficient Expression System for Human Antithrombin III in Baby Hamster Kidney Cells", Behring Inst. Mitt., No. 82, pp. 26-34 (1988).
F. Sanger et al., "DNA Sequencing with Chain-Terminating Inhibitors", Proc. Natl. Acad. Sci. USA, vol. 74, No. 12, pp. 5463-5467. (1977).
A. Hensen et al., "III. Antithrombin III Assay", Thromb. Diatl. Haemorrh.,vol. 9, pp. 18-29 (1963).
J. Schrader et al., "Methoden zur Bestimmung des Antithrombin III (Methods for the Determination of Antithrombin III)", Arztl. Lab., vol. 29, pp. 35-39 (1983).
S. Engelbrecht et al., "Separation of Human Leucocyte Enzymes Alaine Aminopeptidase, Cathepsin G, Collagenase, Elastase and Myeloperoxidase", Hoppe-Seyler's Z. Physiol. Chem., vol. 363, pp. 305-315 (Mar. 1982).
K. Nakajima et al., "Mapping the Extended Substrate Binding Site of Cathepsin G an dHuman Leukocyte Elastase", J. Biol. Chem., vol. 254, No. 10, pp. 4027-4031 (May 1979).

Affiliated with

Also associated with

Rating

Mutants of human antithrobin III and methods for their productio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutants of human antithrobin III and methods for their productio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutants of human antithrobin III and methods for their productio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1801907